| Aug 8 |
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
|
| Aug 8 |
Institutional investors in ADMA Biologics, Inc. (NASDAQ:ADMA) see US$192m decrease in market cap last week, although long-term gains have benefitted them.
|
| Aug 7 |
ADMA Biologics Q2 2024 Earnings Preview
|
| Aug 1 |
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
|
| Jul 31 |
Adma Biologics (ADMA) Rises But Trails Market: What Investors Should Know
|
| Jul 27 |
ADMA Biologics: A Compelling GARP Stock For Biotech Investors
|
| Jul 25 |
Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
|
| Jul 24 |
Adma Biologics (ADMA) Stock Moves -1.31%: What You Should Know
|
| Jul 23 |
Jim Cramer Recommends Not Selling Vertiv, Says Buy This Social Media Stock 'Hand Over Fist'
|
| Jul 22 |
What's in Store for ADMA Biologics (ADMA) in Q2 Earnings?
|
